SKI Market

A+| A| A-|

Indian Indices

Sensex

77,708.52 -442.93
( -0.57%)

Global Indices

Nasdaq

52,169.86 -404.11
(-0.77%)

Dow Jones

7,480.34 -74.43
(-0.99%)

Hang Seng

63,887.74 -2,947.80
(-4.41%)

Nikkei 225

10,542.79 -57.58
(-0.54%)

Forex

USD-INR

96.36 0.10
(0.10%)

EUR-INR

110.37 0.25
(0.23%)

GBP-INR

130.11 0.62
(0.47%)

JPY-INR

0.59 0.00
(0.06%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Alkem Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

539523

INE540L01014

1170.8077615

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ALKEM

29.36

67632.54

EPS(TTM)

Face Value()

Div & Yield %

192.67

0.94

Back

tci finance ltd

Kamdhenu Ventures consolidated net profit declines 50.25% in the December 2025 quarter

Feb 12,2026

Net profit of Kamdhenu Ventures declined 50.25% to Rs 0.99 crore in the quarter ended December 2025 as against Rs 1.99 crore during the previous quarter ended December 2024. Sales declined 14.61% to Rs 63.23 crore in the quarter ended December 2025 as against Rs 74.05 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	63.23	74.05	-15
OPM %	6.28	6.27	-
PBDT	2.91	4.06	-28
PBT	1.46	2.70	-46
NP	0.99	1.99	-50

77,708.52 -442.93 ( -0.57%)

52,169.86 -404.11 (-0.77%)

7,480.34 -74.43 (-0.99%)

63,887.74 -2,947.80 (-4.41%)

10,542.79 -57.58 (-0.54%)

96.36 0.10 (0.10%)

110.37 0.25 (0.23%)

130.11 0.62 (0.47%)

0.59 0.00 (0.06%)